| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
82,823,000 |
| Market
Cap: |
1.67(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$18.92 - $29.92 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 484 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Veracyte is a genomic diagnostics company. Co. develops tests that address clinical needs in the diagnosis, prognosis and treatment of cancer and other diseases. Co. provides tests in: thyroid cancer via its Afirma Genomic Sequencing Classifier (GSC) and Xpression Atlas; prostate cancer via its Decipher Biopsy and Radical Prostatectomy Genomic Classifiers; breast cancer via its Prosigna Breast Cancer Assay; lung cancer via its Percepta GSC and Percepta Nasal Swab Test; interstitial lung diseases including idiopathic pulmonary fibrosis via its Envisia Genomic Classifier; bladder cancer via its Decipher Bladder Genomic Classifier; and colon cancer via its Immunoscore Colon Cancer Test.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
60,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$980,094 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
20,000 |
20,000 |
104,169 |
535,146 |
| Total Sell Value |
$460,127 |
$460,127 |
$2,968,197 |
$14,025,264 |
| Total People Sold |
2 |
2 |
4 |
8 |
| Total Sell Transactions |
2 |
2 |
12 |
30 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hanna John Walter Jr |
Chief Commercial Officer |
• • – |
2020-08-31 |
4 |
OE |
$4.00 |
$475,978 |
D/D |
56,443 |
131,077 |
|
- |
|
| Hanna John Walter Jr |
Chief Commercial Officer |
• • – |
2020-08-21 |
4 |
AS |
$36.00 |
$50,405 |
D/D |
(1,400) |
74,634 |
|
36% |
|
| Hanna John Walter Jr |
Chief Commercial Officer |
• • – |
2020-08-21 |
4 |
OE |
$8.86 |
$12,404 |
D/D |
1,400 |
76,034 |
|
- |
|
| Anderson Bonnie H |
Chairman and CEO |
• • – |
2020-08-10 |
4 |
OE |
$32.22 |
$644,478 |
D/D |
20,000 |
222,207 |
|
- |
|
| Anderson Bonnie H |
Chairman and CEO |
• • – |
2020-08-10 |
4 |
OE |
$8.86 |
$177,200 |
D/D |
20,000 |
242,207 |
|
- |
|
| Anderson Bonnie H |
Chairman and CEO |
• • – |
2020-08-06 |
4 |
GA |
$0.00 |
$0 |
I/I |
50,000 |
25,000 |
|
- |
|
| Anderson Bonnie H |
Chairman and CEO |
• • – |
2020-08-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
50,000 |
222,207 |
|
- |
|
| Jones Evan/ Fa |
Director |
• • – |
2020-08-03 |
4 |
AS |
$35.13 |
$703,117 |
I/I |
(20,000) |
69,653 |
|
57% |
|
| Jones Evan/ Fa |
Director |
• • – |
2020-07-31 |
4 |
AS |
$35.56 |
$713,306 |
I/I |
(20,000) |
89,653 |
|
56% |
|
| Hanna John Walter Jr |
Chief Commercial Officer |
• • – |
2020-07-31 |
4 |
AS |
$36.12 |
$509,145 |
D/D |
(14,095) |
74,634 |
|
56% |
|
| Hanna John Walter Jr |
Chief Commercial Officer |
• • – |
2020-07-31 |
4 |
OE |
$8.86 |
$124,882 |
D/D |
14,095 |
88,729 |
|
- |
|
| Kennedy Giulia C |
Chief Scientific & Med Officer |
• • – |
2020-07-31 |
4 |
AS |
$35.33 |
$706,694 |
D/D |
(20,000) |
80,487 |
|
56% |
|
| Kennedy Giulia C |
Chief Scientific & Med Officer |
• • – |
2020-07-31 |
4 |
OE |
$20.21 |
$404,200 |
D/D |
20,000 |
100,487 |
|
- |
|
| Anderson Bonnie H |
Chairman and CEO |
• • – |
2020-07-30 |
4 |
AS |
$32.24 |
$366,399 |
D/D |
(11,365) |
272,207 |
|
72% |
|
| Anderson Bonnie H |
Chairman and CEO |
• • – |
2020-07-30 |
4 |
OE |
$8.86 |
$100,694 |
D/D |
11,365 |
283,572 |
|
- |
|
| Anderson Bonnie H |
Chairman and CEO |
• • – |
2020-07-23 |
4 |
AS |
$32.04 |
$105,106 |
D/D |
(3,280) |
272,207 |
|
81% |
|
| Anderson Bonnie H |
Chairman and CEO |
• • – |
2020-07-23 |
4 |
OE |
$8.86 |
$29,061 |
D/D |
3,280 |
275,487 |
|
- |
|
| Anderson Bonnie H |
Chairman and CEO |
• • – |
2020-07-22 |
4 |
AS |
$32.00 |
$3,200 |
D/D |
(100) |
272,207 |
|
75% |
|
| Anderson Bonnie H |
Chairman and CEO |
• • – |
2020-07-22 |
4 |
OE |
$8.86 |
$886 |
D/D |
100 |
272,307 |
|
- |
|
| Anderson Bonnie H |
Chairman and CEO |
• • – |
2020-07-21 |
4 |
AS |
$32.09 |
$110,614 |
D/D |
(3,447) |
272,207 |
|
74% |
|
| Anderson Bonnie H |
Chairman and CEO |
• • – |
2020-07-21 |
4 |
OE |
$8.86 |
$30,540 |
D/D |
3,447 |
275,654 |
|
- |
|
| Hanna John Walter Jr |
Chief Commercial Officer |
• • – |
2020-07-21 |
4 |
AS |
$32.36 |
$21,131 |
D/D |
(653) |
74,524 |
|
74% |
|
| Hanna John Walter Jr |
Chief Commercial Officer |
• • – |
2020-07-21 |
4 |
OE |
$2.40 |
$1,567 |
D/D |
653 |
75,177 |
|
- |
|
| Anderson Bonnie H |
Chairman and CEO |
• • – |
2020-07-20 |
4 |
AS |
$32.04 |
$651,911 |
D/D |
(20,349) |
272,207 |
|
71% |
|
| Anderson Bonnie H |
Chairman and CEO |
• • – |
2020-07-20 |
4 |
OE |
$4.00 |
$171,287 |
D/D |
20,349 |
292,556 |
|
- |
|
524 Records found
|
|
Page 10 of 21 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.91 (4.33%) 
